AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INSPIRATION HEALTHCARE GROUP PLC

Interim / Quarterly Report Sep 12, 2019

7711_rns_2019-09-12_acff5c3b-b004-49aa-ba33-14b56ce65df5.html

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0437M

Inspiration Healthcare Group PLC

12 September 2019

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

Notice of Interim Results

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company, will announce its interim results for the six months ended 31 July 2019 on Wednesday 2nd October 2019. 

A presentation to analysts and investors hosted by Neil Campbell, Chief Executive Officer, and Mike Briant, Chief Financial Officer, will be held on Wednesday 2nd October at 9.30am at the offices of Cenkos Securities plc, 6-8 Tokenhouse Yard, London EC2R 7AS. If you would like to register to attend this presentation please contact Alex Walters as per the contact details below.

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer
Tel: 01455 840555
Nominated Adviser & Broker

Cenkos Securities plc

Stephen Keys

Cameron MacRitchie
Tel: 0207 397 8900
Cadogan PR                                             

Alex Walters

[email protected]
Tel: 07771 713608

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NORLLFFAASILLIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.